Comparison between intralesional injection of zinc sulfate 2 % solution and intralesional meglumine antimoniate in the treatment of acute old world dry type cutaneous leishmaniasis: a randomized double-blind clinical trial

Journal of Parasitic Diseases

Volumn 40, Issue 3, 2016, Pages 935-939

  Farajzadeh, Saeedeh ^a   Hakimi Parizi, Maryam ^a   Haghdoost, Ali Akbar ^b   Mohebbi, Azadeh ^c   Mohammadi, Saman ^c   Pardakhty, Abbas ^d   Eybpoosh, Sana ^e   Heshmatkhah, Amireh ^c   Vares, Behrooz ^c   Saryazdi, Simin ^c   Fekri, Ali Reza ^c   Mohebbi, Elham ^f  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^f KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cutaneous leishmaniasis; Glucantime; Intralesional; Zinc sulfate

Indexed keywords

ANTILEISHMANIAL AGENT; MEGLUMINE ANTIMONATE; ZINC SULFATE;

ADULT; ARTICLE; CLINICAL ASSESSMENT; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; CRYOSURGERY; DOUBLE BLIND PROCEDURE; FEMALE; HAZARD RATIO; HUMAN; HYPERSENSITIVITY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SKIN LEISHMANIASIS;

EID: 84911414382     PISSN: 09717196     EISSN: 09750703     Source Type: Journal    
DOI: 10.1007/s12639-014-0609-1     Document Type: Article

References (18)

1. Al majalio O, Routh HB (1997) A two year study of liquid nitrogen therapy in cutaneous leishmaniasis. Int J Dermatol 36(6):36–460
2. Ashford RW (2000) The leishmaniasis as emerging and reemerging zoonoses. Int J Parasitol 30:1269–1281
3. Dogra J, Aneja N, Lal BB, Mishra SN (1990) Cutaneous leishmaniasis in India: clinical experience with itraconazole. Int J Dermatol 29:661–662
4. Esfandiarpour I, Alavi F (1997) Evaluating the efficacy of allopurinol and meglumine antimoniate (Glucantime) in the treatment of cutaneous leishmaniasis: a pilot study. Int J Dermatol 36(1):59–60
5. Firooz A, Khatami A, Khamesipour A, Nassiri-Kashani M, Behnia F, Nilforoushzadeh M, Pazoki-Toroudi H, Dowlati Y (2004) Intralesional injection of 2 % zinc sulfate solution in the treatment of acute old world cutaneous leishmaniasis: a randomized, double-blinded, controlled clinical trial. J Drug Dermatol 4:73–77
6. Iraji F, Vali A, Asilian A, Shahtalebi MA, Momeni AZ (2004) Comparison of intralesionally injected zinc sulfate with meglumine antimoniate in the treatment of acute cutaneous leishmaniasis. Dermatology 209(1):46–49
7. Maleki M, Karimi Gh, Tafaghodi M, Raftari S, Nahidi Y (2012) Comparison of intralesional two percent zinc sulfate and glucantime injection in treatment of acute cutaneous leishmaniasis. Indian J Dermatol 57(2):118–122
8. Minodier P, Parola P (2007) Cutaneous leishmaniasis treatment. Travel Med Infect Dis J 5:150–158
9. Najim RA (1998) Zinc sulfate in the treatment of cutaneous leishmaniasis: an in vitro and animal study. Inst Oswaldo Cruz 93:831–833
10. Najim RA, Sharquie KE, Al-Zubaidy SA (2006) Possible mechanisms of action of the compounds injected intralesionally in the treatment of cutaneous leishmaniasis, in addition to their direct effects on the parasites. Ann Trop Med Parasitol 100(1):33–38
11. Prasad AS (2009a) Zinc: role in immunity, oxidative stress and chronic inflammation. Curr Opin Clin Nutr Metab Care 12:646–652
12. Prasad AS (2009b) Impact of the discovery of human zinc deficiency on health. J Am Coll Nutr 28:257–265
13. Prata A, Silva-Vergara ML, Costa L, Rocha A, Krolewiecki A, Silva JC, de Paula EV, Pimenta Junior FG, Giraldo LE (2003) Efficacy of azithromycin in the treatment of cutaneous leishmaniasis. Rev Soc Bras Med Trop 36(1):65–69
14. Sharifi I, Fekri AR, Aflatonian MR, Nadim A, Nikian Y, Kamesipour A (1998) Cutaneous leishmaniasis in primary school children in the south-eastern Iranian city of Bam, 1994–1995. Bull World Health Organ 76(3):289–293
15. Sharifi F, Sharifi I, Zarean M, Hakimi Parizi M, Aflatoonian M, Harandi MF, Zahmatkesh R, Mashayekhi M, Kermanizadeh A (2012) Spatial distribution and molecular identification of Leishmania species from endemic foci of south-eastern Iran. Iran J Parasitol 7(1):45–52
16. Sharquie KL, Najim RA, Farouj IB (1997) Comparative controlled trial of intralesionally administered zinc sulfate, hypertonic sodium chloride and pentavalent antimony compound against acute cutaneous leishmaniasis. Clin Exp Dermatol 22:169–173
17. Sharquie KE, Najim RA, Farjou IB, Al-Timimi DJ (2001) Oral zinc sulfate in the treatment of acute cutaneous leishmaniasis. Clin Exp Dermatol 26:21–26
18. World Health Organization (1984) The leishmaniasis. Report of a WHO expert committee. WHO Tech Rep Ser 701